From ischaemia to heart failure: Heart rate - Actor or stamper?

被引:1
|
作者
Lechat, P [1 ]
机构
[1] Hop La Pitie Salpetriere, Serv Pharmacol, F-75013 Paris, France
来源
THERAPIE | 2004年 / 59卷 / 05期
关键词
heart rate; ischaemia; contractility; beta-blocker; ivabradine; heart failure;
D O I
10.2515/therapie:2004084
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The heart rate in sinus rhythm depends on I-f current-induced automaticity of sinus node cells. Such a current is activated by hyperpolarisation and is modulated by influences from sympathetic and para-sympathetic tones. There are established prognostic values for the baseline heart rate and its variability in coronary heart disease and heart failure. However. heart rate per se directly modulates myocardial oxygen consumption and cardiac contractility by interfering with the excitation-contraction coupling. The therapeutic implications of pharmacological modulation of the heart rate are important mainly for slowing the heart rate, as illustrated by the use of calcium antagonists in coronary heart disease and beta-blockers in both coronary heart disease and heart failure. The possibility of a direct action on sinusal automaticity by drugs such as ivabradine, an I-f channel blocker, reveals new therapeutic perspectives. Indeed, a benefit of combination therapy with these drugs and beta-blockers should be lower heart rate values than can be attained with maximally tolerated doses of beta-blockers.
引用
收藏
页码:485 / 489
页数:5
相关论文
共 50 条
  • [31] Heart rate and blood pressure monitoring in heart failure
    Ponikowski, Piotr
    Spoletini, Ilaria
    Coats, Andrew J. S.
    Piepoli, Massimo F.
    Rosano, Giuseppe M. C.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0M) : M13 - M16
  • [32] Heart Rate Predicts Mortality in Patients With Heart Failure and Preserved Systolic Function
    Kapoor, John R.
    Heidenreich, Paul A.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (10) : 806 - 811
  • [33] Heart rate control in patients with left ventricular systolic dysfunction and heart failure
    Pourdjabbar, Ali
    Dwivedi, Girish
    Haddad, Ruba
    Saikali, Anthony
    Mielniczuk, Lisa
    Haddad, Haissam
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 276 - 277
  • [34] The role of heart rate and ivabradine in acute heart failure
    Sciatti, Edoardo
    Vizzardi, Enrico
    Dallapellegrina, Lucia
    Bonadei, Ivano
    Carubelli, Valentina
    MONALDI ARCHIVES FOR CHEST DISEASE, 2019, 89 (03) : 11 - 16
  • [35] Heart Rate in Preserved Ejection Fraction Heart Failure
    Bristow, Michael R.
    Altman, Natasha L.
    JACC-HEART FAILURE, 2017, 5 (11) : 792 - 794
  • [36] Effects of shensongyangxin capsule on heart rate turbulence and heart rate variability in chronic heart failure
    Yang Zhen
    Yu Xin
    Yu Mei-ling
    CHINESE MEDICAL JOURNAL, 2013, 126 (22) : 4389 - 4391
  • [37] The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
    Voors, Adriaan A.
    van Veldhuisen, Dirk J.
    Robertson, Michele
    Ford, Ian
    Borer, Jeffrey S.
    Boehm, Michael
    Komajda, Michel
    Swedberg, Karl
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (04) : 426 - 434
  • [38] Decreasing heart rate in heart failure: pros and cons
    Natale, Enrico
    Marsocci, Alfiera
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 : E96 - E98
  • [39] Role of heart rate as a marker and mediator of poor outcome for patients with heart failure
    John R. Kapoor
    Paul A. Heidenreich
    Current Heart Failure Reports, 2012, 9 (2) : 133 - 138
  • [40] Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure
    Tondi, Lara
    Fragasso, Gabriele
    Spoladore, Roberto
    Pinto, Giuseppe
    Gemma, Marco
    Slavich, Massimo
    Godino, Cosmo
    Salerno, Anna
    Montanaro, Claudia
    Margonato, Alberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (07) : 351 - 356